Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | CLPTM1 | Human | 1,2-dimethylhydrazine | multiple interactions | ISO | Clptm1 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CLPTM1 mRNA | CTD | PMID:22206623 | CLPTM1 | Human | 14-Deoxy-11,12-didehydroandrographolide | decreases expression | EXP | | 6480464 | 14-deoxy-11 and 12-didehydroandrographolide results in decreased expression of CLPTM1 mRNA | CTD | PMID:22101062 | CLPTM1 | Human | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of CLPTM1 mRNA | CTD | PMID:16705744 | CLPTM1 | Human | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of CLPTM1 mRNA | CTD | PMID:19167446 | CLPTM1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Clptm1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CLPTM1 mRNA | CTD | PMID:21570461 | CLPTM1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Clptm1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CLPTM1 mRNA | CTD | PMID:33387578 | CLPTM1 | Human | 2,3-dimethoxynaphthalene-1,4-dione | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:17547211 | CLPTM1 | Human | 2,6-dinitrotoluene | affects expression | ISO | Clptm1 (Rattus norvegicus) | 6480464 | 2 and 6-dinitrotoluene affects the expression of CLPTM1 mRNA | CTD | PMID:21346803 | CLPTM1 | Human | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Clptm1 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of CLPTM1 mRNA | CTD | PMID:20188158 | CLPTM1 | Human | 4,4'-sulfonyldiphenol | increases expression | EXP | | 6480464 | bisphenol S results in increased expression of CLPTM1 protein | CTD | PMID:34186270 | CLPTM1 | Human | 4,4'-sulfonyldiphenol | multiple interactions | ISO | Clptm1 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CLPTM1 mRNA | CTD | PMID:36041667 | CLPTM1 | Human | acrolein | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CLPTM1 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CLPTM1 mRNA | CTD | PMID:32699268 | CLPTM1 | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of CLPTM1 gene | CTD | PMID:27153756 | CLPTM1 | Human | Aflatoxin B2 alpha | decreases methylation | EXP | | 6480464 | aflatoxin B2 results in decreased methylation of CLPTM1 intron | CTD | PMID:30157460 | CLPTM1 | Human | alpha-pinene | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CLPTM1 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CLPTM1 mRNA | CTD | PMID:32699268 | CLPTM1 | Human | antimony(0) | decreases expression | EXP | | 6480464 | Antimony results in decreased expression of CLPTM1 mRNA | CTD | PMID:17547211 | CLPTM1 | Human | aristolochic acid A | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of CLPTM1 mRNA | CTD | PMID:33212167 | CLPTM1 | Human | benzo[a]pyrene | decreases expression | ISO | Clptm1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of CLPTM1 mRNA | CTD | PMID:22228805 | CLPTM1 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of CLPTM1 intron | CTD | PMID:30157460 | CLPTM1 | Human | benzo[e]pyrene | affects methylation | EXP | | 6480464 | benzo(e)pyrene affects the methylation of CLPTM1 intron | CTD | PMID:30157460 | CLPTM1 | Human | beta-lapachone | increases expression | EXP | | 6480464 | beta-lapachone results in increased expression of CLPTM1 mRNA | CTD | PMID:38218311 | CLPTM1 | Human | bisphenol A | affects expression | ISO | Clptm1 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of CLPTM1 mRNA | CTD | PMID:25181051 | CLPTM1 | Human | bisphenol A | multiple interactions | ISO | Clptm1 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CLPTM1 mRNA | CTD | PMID:36041667 | CLPTM1 | Human | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CLPTM1 protein | CTD | PMID:37567409 | CLPTM1 | Human | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CLPTM1 mRNA and bisphenol A results in increased expression of CLPTM1 protein | CTD | PMID:29275510 and PMID:34186270 | CLPTM1 | Human | Bisphenol B | increases expression | EXP | | 6480464 | bisphenol B results in increased expression of CLPTM1 protein | CTD | PMID:34186270 | CLPTM1 | Human | bisphenol F | multiple interactions | ISO | Clptm1 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CLPTM1 mRNA | CTD | PMID:36041667 | CLPTM1 | Human | bisphenol F | increases expression | EXP | | 6480464 | bisphenol F results in increased expression of CLPTM1 protein | CTD | PMID:34186270 | CLPTM1 | Human | bortezomib | decreases expression | EXP | | 6480464 | Bortezomib results in decreased expression of CLPTM1 mRNA | CTD | PMID:20977926 | CLPTM1 | Human | C60 fullerene | increases expression | ISO | Clptm1 (Rattus norvegicus) | 6480464 | fullerene C60 results in increased expression of CLPTM1 mRNA | CTD | PMID:19167457 | CLPTM1 | Human | chromium atom | decreases expression | EXP | | 6480464 | Chromium results in decreased expression of CLPTM1 mRNA | CTD | PMID:17547211 | CLPTM1 | Human | clobetasol | increases expression | ISO | Clptm1 (Mus musculus) | 6480464 | Clobetasol results in increased expression of CLPTM1 mRNA | CTD | PMID:27462272 | CLPTM1 | Human | dioxygen | multiple interactions | ISO | Clptm1 (Mus musculus) | 6480464 | [sulforaphane affects the susceptibility to Oxygen] which affects the expression of CLPTM1 mRNA | CTD | PMID:30529165 | CLPTM1 | Human | dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate | decreases expression | EXP | | 6480464 | Antimony Potassium Tartrate results in decreased expression of CLPTM1 mRNA | CTD | PMID:17547211 | CLPTM1 | Human | disodium selenite | decreases expression | EXP | | 6480464 | Sodium Selenite results in decreased expression of CLPTM1 mRNA | CTD | PMID:18175754 | CLPTM1 | Human | doxorubicin | affects response to substance | EXP | | 6480464 | CLPTM1 mRNA affects the susceptibility to Doxorubicin | CTD | PMID:16243817 | CLPTM1 | Human | elemental selenium | increases expression | EXP | | 6480464 | Selenium results in increased expression of CLPTM1 mRNA | CTD | PMID:19244175 | CLPTM1 | Human | ethanol | affects splicing | ISO | Clptm1 (Mus musculus) | 6480464 | Ethanol affects the splicing of CLPTM1 mRNA | CTD | PMID:30319688 | CLPTM1 | Human | fenthion | increases expression | ISO | Clptm1 (Mus musculus) | 6480464 | Fenthion results in increased expression of CLPTM1 mRNA | CTD | PMID:34813904 | CLPTM1 | Human | folic acid | multiple interactions | ISO | Clptm1 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CLPTM1 mRNA | CTD | PMID:22206623 | CLPTM1 | Human | genistein | decreases expression | EXP | | 6480464 | Genistein results in decreased expression of CLPTM1 mRNA | CTD | PMID:16705744 | CLPTM1 | Human | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of CLPTM1 protein | CTD | PMID:32959892 | CLPTM1 | Human | leflunomide | decreases expression | EXP | | 6480464 | leflunomide results in decreased expression of CLPTM1 mRNA | CTD | PMID:28988120 | CLPTM1 | Human | mercury atom | decreases expression | EXP | | 6480464 | Mercury results in decreased expression of CLPTM1 mRNA | CTD | PMID:17547211 | CLPTM1 | Human | mercury atom | increases expression | EXP | | 6480464 | Mercury results in increased expression of CLPTM1 mRNA | CTD | PMID:16823088 | CLPTM1 | Human | mercury(0) | decreases expression | EXP | | 6480464 | Mercury results in decreased expression of CLPTM1 mRNA | CTD | PMID:17547211 | CLPTM1 | Human | mercury(0) | increases expression | EXP | | 6480464 | Mercury results in increased expression of CLPTM1 mRNA | CTD | PMID:16823088 | CLPTM1 | Human | methapyrilene | affects methylation | EXP | | 6480464 | Methapyrilene affects the methylation of CLPTM1 intron | CTD | PMID:30157460 | CLPTM1 | Human | methidathion | increases expression | ISO | Clptm1 (Mus musculus) | 6480464 | methidathion results in increased expression of CLPTM1 mRNA | CTD | PMID:34813904 | CLPTM1 | Human | methotrexate | affects response to substance | EXP | | 6480464 | CLPTM1 protein affects the susceptibility to Methotrexate | CTD | PMID:16217747 | CLPTM1 | Human | methotrexate | decreases expression | EXP | | 6480464 | Methotrexate results in decreased expression of CLPTM1 mRNA | CTD | PMID:17400583 | CLPTM1 | Human | N-nitrosodimethylamine | decreases expression | EXP | | 6480464 | Dimethylnitrosamine results in decreased expression of CLPTM1 mRNA | CTD | PMID:17547211 | CLPTM1 | Human | nickel dichloride | decreases expression | EXP | | 6480464 | nickel chloride results in decreased expression of CLPTM1 mRNA | CTD | PMID:17547211 | CLPTM1 | Human | ozone | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CLPTM1 mRNA more ... | CTD | PMID:32699268 | CLPTM1 | Human | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of CLPTM1 mRNA | CTD | PMID:22230336 | CLPTM1 | Human | paracetamol | increases expression | ISO | Clptm1 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of CLPTM1 mRNA | CTD | PMID:33387578 | CLPTM1 | Human | perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of CLPTM1 protein | CTD | PMID:26879310 | CLPTM1 | Human | potassium dichromate | decreases expression | EXP | | 6480464 | Potassium Dichromate results in decreased expression of CLPTM1 mRNA | CTD | PMID:17547211 | CLPTM1 | Human | selenium atom | increases expression | EXP | | 6480464 | Selenium results in increased expression of CLPTM1 mRNA | CTD | PMID:19244175 | CLPTM1 | Human | sulforaphane | multiple interactions | ISO | Clptm1 (Mus musculus) | 6480464 | [sulforaphane affects the susceptibility to Oxygen] which affects the expression of CLPTM1 mRNA | CTD | PMID:30529165 | CLPTM1 | Human | temozolomide | decreases expression | EXP | | 6480464 | Temozolomide results in decreased expression of CLPTM1 mRNA | CTD | PMID:31758290 | CLPTM1 | Human | thiram | decreases expression | EXP | | 6480464 | Thiram results in decreased expression of CLPTM1 mRNA | CTD | PMID:38568856 | CLPTM1 | Human | trichloroethene | increases expression | ISO | Clptm1 (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased expression of CLPTM1 mRNA | CTD | PMID:33387578 | CLPTM1 | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of CLPTM1 mRNA | CTD | PMID:37042841 | CLPTM1 | Human | triptonide | decreases expression | ISO | Clptm1 (Mus musculus) | 6480464 | triptonide results in decreased expression of CLPTM1 mRNA | CTD | PMID:33045310 | CLPTM1 | Human | urethane | increases expression | EXP | | 6480464 | Urethane results in increased expression of CLPTM1 mRNA | CTD | PMID:28818685 | CLPTM1 | Human | vinclozolin | decreases expression | ISO | Clptm1 (Rattus norvegicus) | 6480464 | vinclozolin results in decreased expression of CLPTM1 mRNA | CTD | PMID:23034163 | |